Invited Commentary
Tacrolimus exposure and intra-patient variability in paediatric and young adult kidney transplant recipients: one size does not fit all
Agnieszka Prytuła,
Corresponding Author
Agnieszka Prytuła
Department of Pediatric Nephrology and Rheumatology, Ghent University Hospital, Ghent, Belgium
Correspondence
Agnieszka Prytuła, Department of Pediatric Nephrology and Rheumatology, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium.
Tel.: +32 9 332 0368;
fax: +32 9 332 2170;
e-mail: [email protected]
Search for more papers by this author
Agnieszka Prytuła,
Corresponding Author
Agnieszka Prytuła
Department of Pediatric Nephrology and Rheumatology, Ghent University Hospital, Ghent, Belgium
Correspondence
Agnieszka Prytuła, Department of Pediatric Nephrology and Rheumatology, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium.
Tel.: +32 9 332 0368;
fax: +32 9 332 2170;
e-mail: [email protected]
Search for more papers by this author
First published: 22 September 2020
No abstract is available for this article.
Conflicts of interest
The author has declared no conflicts of interest.
References
- 1Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562.
- 2Davis S, Gralla J, Klem P, et al. Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation. Am J Transplant 2018; 18: 907.
- 3Prytula A, van Gelder T. Clinical aspects of tacrolimus use in paediatric renal transplant recipients. Pediatr Nephrol 2019; 34: 31.
- 4Gold A, Tonshoff B, Dohler B, Susal C. Association of graft survival with tacrolimus exposure and late intra-patient tacrolimus variability in pediatric and young adult renal transplant recipients – an international CTS registry analysis. Transplant Int 2020. https//doi.org/10.1111/tri.13726. Online ahead of print.
- 5Van Arendonk KJ, James NT, Boyarsky BJ, et al. Age at graft loss after pediatric kidney transplantation: exploring the high-risk age window. Clin J Am Soc Nephrol 2013; 8: 1019.
- 6O'Regan JA, Canney M, Connaughton DM, et al. Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation. J Nephrol 2016; 29: 269.
- 7Vanhove T, Vermeulen T, Annaert P, Lerut E, Kuypers DRJ. High intrapatient variability of tacrolimus concentrations predicts accelerated progression of chronic histologic lesions in renal recipients. Am J Transplant 2016; 16: 2954.
